Patel, Sujal and Talwar, Dhruv and Kumar, Sunil and Acharya, Sourya and Patel, Mansi (2021) Long COVID Syndrome Presenting as Hyperferritenemia Associated Toxic Encephalopathy in a Deferoxamine Compliant Patient of Beta Thalassemia. Journal of Pharmaceutical Research International, 33 (57B). pp. 241-246. ISSN 2456-9119
4793-Article Text-6893-1-10-20221006.pdf - Published Version
Download (513kB)
Abstract
Ferritin overload is a frequent problem encountered in patients with beta thalassemia amounting to various complications. One of rare but important complication of ferritin overload is ferritin overload induced toxic encephalopathy. Serum ferritin has been recognised as a important marker of inflammation and cytokine storm in COVID19.We present a case of Long COVID syndrome presenting as toxic encephalopathy in a case of beta thalassemia in spite of the patient being compliant to desferroxamine therapy.This report highlights the synergistic effect of Severe Acute Respiratory Syndrome Coronavirus. 2(SARS CoV 2) mediated neuroinflammation through direct viral invasion and the release of inflammatory cytokines including ferritin resulting in toxic encephalopathy in a beta thalassemia major patient who was already prone to develop hyperferritenemia.Ferritin functions as a pro-inflammatory cytokine and it’s level increases in both thalassemia and COVID-19 and the index case presented here had both the conditions predisoposing him to develop toxic encephalopathy even after being compliant to deferoxamine therapy. It is important to recognise and treat this condition in order to prevent mortality and morbidity in patients of beta thalassemia who contract COVID19.
Item Type: | Article |
---|---|
Subjects: | Pustakas > Medical Science |
Depositing User: | Unnamed user with email support@pustakas.com |
Date Deposited: | 08 Mar 2023 12:41 |
Last Modified: | 10 Feb 2024 04:11 |
URI: | http://archive.pcbmb.org/id/eprint/63 |